Scarica l'app Stockscreener
8.58
1.90%
0.16
Dopo l'orario di chiusura:
8.59
0.010
+0.12%
Precedente Chiudi:
$8.42
Aprire:
$8.545
Volume 24 ore:
4.42M
Relative Volume:
0.70
Capitalizzazione di mercato:
$1.51B
Reddito:
$2.59B
Utile/perdita netta:
$-981.73M
Rapporto P/E:
-1.487
EPS:
-5.77
Flusso di cassa netto:
$206.95M
1 W Prestazione:
+8.88%
1M Prestazione:
+8.75%
6M Prestazione:
-15.38%
1 anno Prestazione:
-7.74%
Intervallo 1D:
$8.50
$8.74
Intervallo di 1 settimana:
$7.825
$8.81
Portata 52W:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Nome
Teladoc Health Inc
Settore
Industria
Telefono
(203) 635-2002
Indirizzo
2 MANHATTANVILLE ROAD, PURCHASE, NY
Confronta TDOC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
8.58 | 1.48B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
286.01 | 46.61B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
64.86 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
96.91 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
61.00 | 11.13B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.96 | 6.33B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-15 | Iniziato | Goldman | Buy |
| 2024-09-17 | Reiterato | Jefferies | Hold |
| 2024-02-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-17 | Downgrade | DA Davidson | Buy → Neutral |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-04-12 | Iniziato | Stephens | Equal-Weight |
| 2023-02-23 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Aggiornamento | Guggenheim | Sell → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-17 | Downgrade | Guggenheim | Neutral → Sell |
| 2022-08-12 | Iniziato | DA Davidson | Buy |
| 2022-08-02 | Downgrade | Berenberg | Buy → Hold |
| 2022-08-02 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-07-28 | Downgrade | Goldman | Buy → Neutral |
| 2022-07-28 | Downgrade | Needham | Buy → Hold |
| 2022-07-06 | Reiterato | BofA Securities | Neutral |
| 2022-05-05 | Downgrade | Argus | Buy → Hold |
| 2022-04-28 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-28 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-04-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-03 | Aggiornamento | Argus | Hold → Buy |
| 2022-02-23 | Reiterato | BofA Securities | Neutral |
| 2022-02-23 | Reiterato | Craig Hallum | Hold |
| 2022-02-23 | Reiterato | Evercore ISI | In-line |
| 2022-02-23 | Reiterato | Goldman | Buy |
| 2022-02-23 | Reiterato | JP Morgan | Overweight |
| 2022-02-23 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Reiterato | Needham | Buy |
| 2022-02-23 | Reiterato | Oppenheimer | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2022-02-08 | Reiterato | Piper Sandler | Overweight |
| 2021-12-02 | Ripresa | Jefferies | Hold |
| 2021-11-22 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-10-28 | Reiterato | Barclays | Equal Weight |
| 2021-10-28 | Reiterato | BofA Securities | Neutral |
| 2021-10-28 | Reiterato | Canaccord Genuity | Buy |
| 2021-10-28 | Reiterato | Citigroup | Buy |
| 2021-10-28 | Reiterato | Craig Hallum | Hold |
| 2021-10-28 | Reiterato | Needham | Buy |
| 2021-10-28 | Reiterato | Oppenheimer | Outperform |
| 2021-10-28 | Reiterato | Piper Sandler | Overweight |
| 2021-10-28 | Reiterato | UBS | Neutral |
| 2021-10-19 | Iniziato | Wells Fargo | Overweight |
| 2021-08-02 | Downgrade | Argus | Buy → Hold |
| 2021-07-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-15 | Iniziato | Needham | Buy |
| 2021-01-07 | Iniziato | BTIG Research | Buy |
| 2020-12-22 | Iniziato | Evercore ISI | In-line |
| 2020-12-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Iniziato | Goldman | Neutral |
| 2020-11-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Iniziato | DA Davidson | Buy |
| 2020-09-02 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-08-17 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Iniziato | Citigroup | Buy |
| 2020-07-13 | Iniziato | Argus | Buy |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-04-30 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Iniziato | SVB Leerink | Outperform |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-25 | Downgrade | Craig Hallum | Buy → Hold |
| 2020-03-16 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Iniziato | UBS | Neutral |
| 2020-01-09 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Teladoc Health Inc Borsa (TDOC) Ultime notizie
Teladoc Secures $300M Credit Facility with JPMorgan - TipRanks
Recent Uptick Might Appease Teladoc Health, Inc. (NYSE:TDOC) Institutional Owners After Losing 9.5% Over the Past Year - 富途牛牛
Virtual Care Market Growth Surges Amid Digital Health Trends - openPR.com
Is Teladoc Health Inc. a good long term investmentMarket-crushing profits - Autocar Professional
The Zacks Analyst Blog Highlights Hims & Hers Health, Teladoc Health and American Well - TradingView
Future Scope of Digital Medical Home Services Market to Observe - openPR.com
What drives Teladoc Health Inc. stock priceRapid market gains - jammulinksnews.com
Hims & Hers Paves the Way for Global Digital Health Expansion - Nasdaq
Contrarian Value Investing in Teladoc Health: A Case for Earnings Catalyst Potential Amid Market Doubts - AInvest
Teladoc (TDOC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Virtual Health Service Market Is Booming So Rapidly 2025-2032Teladoc Health, Amwell, Doctor on Demand, MDLive - openPR.com
Teladoc Health Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com
What analysts say about Teladoc Health Inc. stockFree Investment Community - Autocar Professional
Teladoc Health, Inc. Common Stock (NYSE:TDOC) Stock Quote - FinancialContent
5 Undervalued AI Stocks Set for a Second-Half 2025 Rebound - AInvest
Lobbying Update: $160,000 of TELADOC HEALTH INC. lobbying was just disclosed - Nasdaq
How Hims & Hers Health Is Quietly Changing Healthcare (NYSE:HIMS) - Seeking Alpha
Teladoc Health’s Turnaround Plan Faces Profit Potholes - Finimize
Teladoc Health Requests to Dismiss Class Action Filed by Investors - TradingView
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? - Yahoo Finance
Telehealth Services Market Surges on Remote Patient Monitoring - openPR.com
Virtual Hospitalization Solutions Market Future Trend - openPR.com
Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally? - TradingView
Teladoc Health shares rise 3.49% intraday after Mobile-health Network Solutions launched a $300 million ATM equity offering. - AInvest
Distance Health Technology Market Growth Driven - openPR.com
Teladoc Health Inc. to Release Second Quarter 2025 Results and Host Conference Call on July 29 - Quiver Quantitative
Teladoc Health to Announce Second Quarter 2025 Financial Results - GlobeNewswire
Virtual Care Leader Teladoc Health Sets Q2 2025 Earnings Release DateKey Details for Investors - Stock Titan
Lyft to Announce Second Quarter 2025 Financial Results - The Globe and Mail
Teladoc Launches Employee Assistance Program, Expanding Mental Healthcare Offerings - AInvest
Telehealth Heats Up With Teladoc, Livongo Health $18B Merger - PYMNTS.com
Teladoc Health Launches Wellbound Employee Assistance Program - HIT Consultant
CPR Strategic Marketing Communications Highlighted in New Book: Telemedicine Wars, Authored by the Founders of Teladoc - TradingView
AI Telehealth Platform Solutions Market in 2032: A Glimpse Into - openPR.com
Teladoc to launch employee assistance program - Healthcare Dive
Teladoc Health Launches Wellbound Employee Assistance Program to Enhance Workforce Wellness - Nasdaq
Teladoc Health Launches Wellbound Employee Assistance Program (EAP) - GlobeNewswire
Teladoc Revolutionizes Employee Mental Health with New Integrated Wellbound Platform, Partners with BetterHelp - Stock Titan
What makes Teladoc Health Inc. stock price move sharplyGrowth Stock Monitor - beatles.ru
Jurisdictional Battles Over Abortion Access: Navigating Regulatory Risks in Healthcare Stocks - AInvest
Patient Support Programs (PSP) Market Growing with - openPR.com
Internet Hospital Market Is Booming So Rapidly By 2032 | Teladoc Health, Amwell, Doctor On Demand, Practo - openPR.com
Digital Mental Health Services Market Is Booming So Rapidly By 2032 | Talkspace, Inc., BetterHelp, Headspace, Inc. - openPR.com
Online Couples Therapy & Counseling Services Market Is Booming - openPR.com
Teladoc Health Inc Azioni (TDOC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):